Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$10.20
0.464.67%
Last update: Jun 9, 5:02 PM
$10.04
0.293.03%
ProMIS Neurosciences Inc Analyst Ratings
PMNNASDAQ
ProMIS Neurosciences Analyst Ratings and Price Targets | NASDAQ:PMN | Benzinga
ProMIS Neurosciences Inc has a consensus price target of $16 based on the ratings of 4 analysts. The high is $35 issued by Guggenheim on February 6, 2026. The low is $3 issued by Maxim Group on May 12, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Guggenheim, and HC Wainwright & Co. on June 8, 2026, February 6, 2026, and December 1, 2025, respectively. With an average price target of $23.67 between HC Wainwright & Co., Guggenheim, and HC Wainwright & Co., there's an implied 135.72% upside for ProMIS Neurosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Guggenheim
Maxim Group
BTIG
1calculated from analyst ratings
Analyst Ratings for ProMIS Neurosciences
Loading calendar...
FAQ
What is the target price for ProMIS Neurosciences (PMN) stock?
The latest price target for ProMIS Neurosciences (NASDAQ:PMN) was reported by HC Wainwright & Co. on June 8, 2026. The analyst firm set a price target for $18.00 expecting PMN to rise to within 12 months (a possible 79.28% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ProMIS Neurosciences (PMN)?
The latest analyst rating for ProMIS Neurosciences (NASDAQ:PMN) was provided by HC Wainwright & Co., and ProMIS Neurosciences reiterated their buy rating.
When was the last upgrade for ProMIS Neurosciences (PMN)?
There is no last upgrade for ProMIS Neurosciences
When was the last downgrade for ProMIS Neurosciences (PMN)?
There is no last downgrade for ProMIS Neurosciences.
When is the next analyst rating going to be posted or updated for ProMIS Neurosciences (PMN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ProMIS Neurosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ProMIS Neurosciences was filed on June 8, 2026 so you should expect the next rating to be made available sometime around June 8, 2027.
Is the Analyst Rating ProMIS Neurosciences (PMN) correct?
While ratings are subjective and will change, the latest ProMIS Neurosciences (PMN) rating was a reiterated with a price target of $18.00 to $18.00. The current price ProMIS Neurosciences (PMN) is trading at is $10.04, which is out of the analyst’s predicted range.
